Complete report is available @ http://www.rnrmarketresearch.com/pharmapoint-obesity-global-drug-forecast-and-market-analysis-to-2022-market-report.html .
Only one older generation drug with modest efficacy had been available until the recent arrival of two new therapies that could potentially change the prescribing landscape. Will these drugs make a significant impact on the Obesity market? Which drugs are used off-label for the treatment of obesity?